Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Myelodysplastic Syndromes × neratinib × Clear all

Sponsor

Conditions

HER2+ Metastatic Breast Cancer (MBC) 1 Breast Neoplasms 1

Interventions

Decitabine 3 decitabine and cedazuridine drug combination 2 cedazuridine 2 treosulfan 1 luspatercept 1 ivosidenib 1 imetelstat 1 glasdegib 1 enasidenib 1 GRN163L peptide 1 Daunorubicin 1 Cytarabine 1 Busulfan 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡